BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10352362)

  • 1. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function.
    Cruzado JM; Torras J; Riera M; Condom E; Lloberas N; Herrero I; Martorell J; Grinyó JM
    Exp Nephrol; 1999; 7(3):217-28. PubMed ID: 10352362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
    Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
    Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute cell rejection in ex vivo model of swine-human renal xenotransplantation].
    Vega Vega A; García Alonso D; Ramos Barrón A; Val Bernal F; Pino Chávez G; Gómez Fleitas M; Arias Rodríguez M
    Actas Urol Esp; 2004 Feb; 28(2):106-21. PubMed ID: 15074059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of primate xenoreactive natural antibodies by extracorporeal perfusion of pig kidneys and livers.
    Azimzadeh A; Meyer C; Watier H; Beller JP; Chenard-Neu MP; Kieny R; Boudjema K; Jaeck D; Cinqualbre J; Wolf P
    Transpl Immunol; 1998 Mar; 6(1):13-22. PubMed ID: 9640624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of human anti-pig xenoantibodies by soluble GAL alpha 1-3Gal and Gal alpha 1-2Gal disaccharides; studies in a pig kidney in vitro perfusion model.
    Magnusson S; Strokan V; Mölne J; Nilsson K; Rydberg L; Breimer ME
    Transpl Int; 2000; 13(6):402-12. PubMed ID: 11140238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation.
    Meyer C; Wolf P; Romain N; Ravanat C; Roussi J; Beller JP; Imbs P; Chenard MP; Fabre M; Kieny R; Bonneau M; Drouet L; Cazenave JP; Soulillou JP; Azimzadeh A
    Transplantation; 1999 Jan; 67(1):38-45. PubMed ID: 9921793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood.
    Bongoni AK; Kiermeir D; Jenni H; Bähr A; Ayares D; Klymiuk N; Wolf E; Voegelin E; Constantinescu MA; Seebach JD; Rieben R
    Xenotransplantation; 2014; 21(3):230-43. PubMed ID: 24635052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Hammer C
    Transplantation; 1994 Feb; 57(3):358-63. PubMed ID: 8108870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.
    Fiane AE; Videm V; Johansen HT; Mellbye OJ; Nielsen EW; Mollnes TE
    Immunopharmacology; 1999 May; 42(1-3):231-43. PubMed ID: 10408384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation.
    Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F
    J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody depletion and blockage of adhesion molecules prolongs renal xenograft survival in the pig to dog model.
    Henry ML; Bendle MD; Bryan BA; Ferguson RM
    Transplant Proc; 1994 Jun; 26(3):1362. PubMed ID: 8029941
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
    Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
    Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo spleen and kidney absorption of xenoreactive natural antibodies decreases severity of hyperacute rejection in pig-to-dog renal xenotransplantation.
    Nitta K
    Hiroshima J Med Sci; 1996 Dec; 45(4):119-25. PubMed ID: 9119710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells.
    Azimzadeh A; Wolf P; Thibaudeau K; Cinqualbre J; Soulillou JP; Anegon I
    Transplantation; 1997 Oct; 64(8):1166-74. PubMed ID: 9355835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravital microscopic investigation of xenogeneic microcirculation and impact of complement depletion by cobra venom factor.
    Diefenbeck M; Linke R; Seehofer D; Terajima H; Thiery J; Hammer C
    Xenotransplantation; 1998 Nov; 5(4):262-73. PubMed ID: 9915254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
    Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
    Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.